Daejeon-based biotechnology company developing antisense oligonucleotide and mRNA therapies for intractable central nervous system diseases caused by brain somatic mutations, with a focus on precision medicine and rare-disease therapeutics
Daejeon-based biotechnology company developing antisense oligonucleotide and mRNA therapies for intractable central nervous system diseases caused by brain somatic mutations, with a focus on precision medicine and rare-disease therapeutics.